New tool aims to give older leukemia patients a stronger voice in treatment choices

NCT ID NCT04625413

Completed Knowledge-focused Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested a communication tool called UR-GOAL in 15 older adults (age 60+) with newly diagnosed acute myeloid leukemia (AML), along with their caregivers and doctors. The tool helps patients share their preferences and goals, so treatment decisions better match what matters most to them. The study focused on whether the tool is usable and helpful, not on curing the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: UR-GOAL communication tool (a behavioral intervention using conjoint analysis to elicit patient preferences)
What this could lead to: If successful, this tool could help older AML patients and their doctors make more informed, preference-aligned treatment decisions.
What could go wrong: This is a very small pilot study with only 15 participants, so results may not apply broadly. The tool's impact on actual health outcomes is not yet tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA

Contacts and locations

Locations

University of Rochester Medical Center

Rochester, New York, 14623, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.